BLRX - BioLineRx slumps -14% AH on $10M bought-deal offering

BioLineRx (BLRX) has agreed to purchase on a firm commitment basis 4.17M ADSs of the company, at a price to the public of $2.40 per ADS, less underwriting discounts and commissions.Offering is expected to occur on or about January 22, 2021.Gross proceeds are expected to be $10M.Company expects to use the net proceeds from the offering for general corporate purposes, which may include but are not limited to working capital and funding clinical trials.Shares -14% after hoursPress Release

For further details see:

BioLineRx slumps -14% AH on $10M bought-deal offering